// App-Quantinova.ai

1789 : Repurposing the anti-depressant sertraline to target serine/glycine synthesis addicted cancer

Researchers

Presenter

  • Shauni L. Geeraerts

Principal Investigators

  • Kim R. Kampen

  • Gianmarco Rinaldi

  • Purvi Gupta

  • Mlanie Planque

  • Kaat De Cremer

  • Katrijn De Brucker

  • Stijn Vereecke

  • Benno Verbelen

  • Pieter Vermeersch

  • David Cassiman

  • Sarah-Maria Fendt

  • Arnout Voet

  • Bruno P.A. Cammue

  • Karin Thevissen

  • Kim De Keersmaecker

Medical Centers

  • KU Leuven, Leuven, Belgium

  • KU Leuven, Leuven, Belgium

Locations

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • T-cell acute lymphoblastic leukemia

  • Triple-negative breast cancer

  • Acute lymphoblastic leukemia

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Phosphoglycerate Dehydrogenase

  • Phosphoserine Aminotransferase 1

Drug/Treatment

  • Sertraline

  • Asentra

  • Artemether

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved